Skip to main content
OpenTrials

Clinical trial condition

Dermatitis, Atopic

Explore clinical trials studying Dermatitis, Atopic. Study availability and eligibility vary by location and protocol.

1,194 public trials 150 recruiting studies
Refine in advanced search Browse all conditions

Dermatitis, Atopic trial results

Completed

Phase 2B Study to Evaluate ASN002 in Subjects With Moderate to Severe Atopic Dermatitis (RADIANT)

NCT03531957

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Pinnacle Research Group, LLC Anniston, Alabama, United States
  • Total Skin and Dermatology Center, PC. Birmingham, Alabama, United States
  • Center for Dermatology Clinical Research, Inc. Fremont, California, United States
  • L.A. Universal Research Center, Inc. Los Angeles, California, United States
View all 47 locations
View Trial Details
Completed

Evaluate Efficacy and Safety of Oral SHR0302 in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

NCT04875169

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Dermatology Research Institute Inc. Calgary, Alberta, Canada
  • Dr Chih-ho Hong Medical Inc. Surrey, British Columbia, Canada
  • Enverus Medical Research Surrey, British Columbia, Canada
  • Wiseman Dermatology Research Winnipeg, Manitoba, Canada
View all 52 locations
View Trial Details
Completed

Efficacy, Safety, and Pharmacokinetic Profile of Etokimab (ANB020) in Adult Participants With Moderate-to-Severe Atopic Dermatitis

NCT03533751

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Applied Research Center of Arkansas Little Rock, Arkansas, United States
  • Encino Research Group Encino, California, United States
  • Irvine Center for Clinical Research, Inc. Irvine, California, United States
View all 81 locations
View Trial Details
Completed

Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis

NCT04178967

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Investigate MD Scottsdale, Arizona, United States
  • Northwest Arkansas Clinical Trials Center Rogers, Arkansas, United States
  • Bakersfield Dermatology and Skin Cancer Medical Group Bakersfield, California, United States
  • Center For Dermatology Clinical Research, Inc. Fremont, California, United States
View all 89 locations
View Trial Details
Completed

Observational Study to Evaluate the Actual Use of Elidel® in Chinese Patients With Mild to Moderate Atopic Dermatitis

NCT04976868

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Beijing children's Hospital, Capital Medical University Beijing, China
  • Beijing Hospital Beijing, China
  • Children's Hospital Capital Institute of Pediatrics Beijing, China
  • Peking University First Hospital Beijing, China
View Trial Details

Related conditions